Free Trial

Ekso Bionics (EKSO) Earnings Date, Estimates & Call Transcripts

Ekso Bionics logo
$0.69 -0.03 (-4.16%)
(As of 11/22/2024 ET)

Ekso Bionics Latest Earnings Summary

Upcoming Q4
Earnings Date
Mar. 3Estimated
Actual EPS
(Oct. 28)
-$0.10 Missed By -$0.02
Consensus EPS
(Oct. 28)
-$0.08

Ekso Bionics posted Q3 2024 earnings on October 28, 2024, reporting an EPS of -$0.10, which missed the consensus estimate of -$0.08 by $0.02. Quarterly revenue was reported to be $4.13 million, below analysts' expectations of $6 million. With a trailing EPS of -$0.65, Ekso Bionics' earnings are expected to grow next year, from ($0.48) to ($0.15) per share.

EKSO Upcoming Earnings

Ekso Bionics' next earnings date is estimated for Monday, March 3, 2025, based off prior year's reporting schedules.

Get Ekso Bionics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ekso Bionics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

EKSO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EKSO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ekso Bionics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.16-$0.16-$0.16
Q2 20241-$0.11-$0.11-$0.11
Q3 20241-$0.08-$0.08-$0.08
Q4 20241-$0.06-$0.06-$0.06
FY 20244-$0.41-$0.41-$0.41
Q1 20251-$0.06-$0.06-$0.06
Q2 20251-$0.02-$0.02-$0.02
Q3 20251-$0.04-$0.04-$0.04
Q4 20251-$0.02-$0.02-$0.02
FY 20254($0.14)($0.14)($0.14)

Ekso Bionics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/3/2025
(Estimated)
------- 
10/28/2024Q3 2024-$0.08-$0.10 -$0.02-$0.10$6.00M$4.13M    
7/29/2024Q2 2024-$0.11-$0.13 -$0.02-$0.13$5.34M$4.95M    
4/29/2024Q1 2024-$0.16-$0.20 -$0.04-$0.20$4.99M$3.76M    
3/4/2024Q4 2023-$0.11-$0.22 -$0.11-$0.22$4.80M$4.85M    
10/26/2023Q3 2023-$0.31-$0.24+$0.07-$0.24$4.53M$4.61M
7/27/2023Q2 2023-$0.28-$0.31 -$0.03-$0.31$4.35M$4.70M
I was wrong. Dead wrong. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

4/27/2023Q1 2023-$0.31-$0.33 -$0.02-$0.33$2.80M$4.12M
3/28/2023Q4 2022--$0.24 -$0.24-$0.24-$3.55M

Ekso Bionics Earnings - Frequently Asked Questions

Ekso Bionics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based off last year's report dates. Learn more on EKSO's earnings history.

In the previous quarter, Ekso Bionics (NASDAQ:EKSO) missed the analysts' consensus estimate of ($0.08) by $0.02 with a reported earnings per share (EPS) of ($0.10). Learn more on analysts' earnings estimate vs. EKSO's actual earnings.

The conference call for Ekso Bionics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Ekso Bionics's latest earnings report can be read online.
Read Transcript

Ekso Bionics (NASDAQ:EKSO) has a recorded annual revenue of $18.28 million.

Ekso Bionics (NASDAQ:EKSO) has a recorded net income of -$15.20 million. EKSO has generated -$0.65 earnings per share over the last four quarters.

Ekso Bionics's earnings are expected to grow from ($0.48) per share to ($0.15) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:EKSO) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners